Conversely, noncoding RNAs can modulate tumor progression by regulating Mettl3, leading to reduced expression and functionality of Mettl3, which in turn counteracts its tumor-promoting effects.[17] Aberrant expression of Mettl3 is commonly observed in various tumor types. Here, METTL3 is linked to neoplasm.